Moleculent Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$20M
- Investors
-
5
Moleculent General Information
Description
Operator of a biotechnology company intended to decode human biology with advancements in life science. The company develops technology-enabled products that leverage new insights into the molecular foundation of human biology, enabling healthcare professionals to avail molecular science-based therapies and diagnostics.
Contact Information
Website
www.moleculent.comCorporate Office
- Scheeles Väg 1
- 171 65 Solna
- Sweden
Corporate Office
- Scheeles Väg 1
- 171 65 Solna
- Sweden
Moleculent Timeline
Moleculent Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 30-Apr-2026 | $20M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 11-Jun-2024 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 31-Dec-2022 | $10.2M | $10.2M | Completed | Startup |
Moleculent Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Moleculent Comparisons
Industry
Financing
Details
Moleculent Competitors (29)
One of Moleculent’s 29 competitors is Abcam, a Corporate Backed or Acquired company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| Genewiz | Formerly VC-backed | South Plainfield, NJ | ||||
| Novus Biologicals | Formerly PE-Backed | Centennial, CO | ||||
| CIS Bio International | Formerly PE-Backed | Saclay, France | ||||
| Source Bioscience | Corporation | Nottingham, United Kingdom |
Moleculent Patents
Moleculent Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025133768-A1 | Transfer of reporter probes from a biological sample to a support by direct contact | Inactive | 21-Dec-2023 | ||
| EP-4623102-A1 | Heat-based transfer of reaction products made in situ to a planar support | Pending | 28-Dec-2022 | ||
| US-20260209832-A1 | Heat-based transfer of reaction products made in situ to a planar support | Pending | 28-Dec-2022 | ||
| WO-2024141901-A1 | Heat-based transfer of reaction products made in situ to a planar support | Inactive | 28-Dec-2022 | ||
| AU-2023213160-A1 | Detection of proximity assay products in situ | Pending | 26-Jan-2022 | C12Q1/6841 |
Moleculent Signals
Moleculent Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Rubicon Healthcare Partners | Growth/Expansion | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Eir Ventures | Venture Capital | Minority | ||
| Subvenio Invest | Venture Capital | Minority | ||
| Syntrans | Family Office | Minority |
Moleculent FAQs
-
When was Moleculent founded?
Moleculent was founded in 2021.
-
Where is Moleculent headquartered?
Moleculent is headquartered in Solna, Sweden.
-
What is the size of Moleculent?
Moleculent has 50 total employees.
-
What industry is Moleculent in?
Moleculent’s primary industry is Discovery Tools (Healthcare).
-
Is Moleculent a private or public company?
Moleculent is a Private company.
-
What is Moleculent’s current revenue?
The current revenue for Moleculent is .
-
How much funding has Moleculent raised over time?
Moleculent has raised $57.4M.
-
Who are Moleculent’s investors?
Rubicon Healthcare Partners, ARCH Venture Partners, Eir Ventures, Subvenio Invest, and Syntrans have invested in Moleculent.
-
Who are Moleculent’s competitors?
Abcam, Genewiz, Novus Biologicals, CIS Bio International, and Source Bioscience are some of the 29 competitors of Moleculent.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process